Atrial fibrillation in the setting of left ventricular dysfunction is associated with poor prognosis and its optimal treatment remains controversial.
Supports prognostic discussions in HF-AF; leaves open optimal rhythm versus rate strategies pending RCTs.
Atrial fibrillation (AF) and left ventricular dysfunction (LVD) are increasingly common clinical problems, affecting millions of people worldwide. It is well established that the presence of AF portends a poor prognosis in the setting of both ischemic and non-ischemic LVD, and frequently results in worsening clinical status. Many clinical studies and trials have attempted to address treatment options and efficacy; despite this treatment for AF in LVD is still controversial.
No takes yet. Share an insight, caveat, or question.
Ducas et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: